Pharmaceutical Executive-09-01-2013

The Sunshine Act's Open Payments spending disclosure program is now live. The government's lead compliance officer explains how it will work.

Companies are leveraging combinations of drugs and other products to gain competitive advantage and market share.

Are electronic health records a viable channel for engagement? Ben Comer reports.

A key issue for biopharma marketers today is balancing cost and value factors around specialty biologic drugs, particularly those for cancer and other high profile, lifealtering diseases.

With their knowledge of molecular genetics, Pathologists are transforming the way healthcare is provided.

Normal service will be resumed as soon as possible.

By the start of 2014, industry expects to have a clearer idea of how far the US-EU free trade pact is going.